Our findings, therefore, support the role of TSPX as a tumor suppressor for prostate cancer via its actions in repressing the expression of various cancer-drivers/oncogenes and stimulating those of tumor suppressors. This evidence concerns the gene TSPYL2 and prostate carcinoma.